- category:Business
Business
Harrow launches initiative for expanded access, price cuts of branded products
The company is partnering with GoodRx to provide patients with discounts on select ophthalmic products.
Business
Harrow partners with Asembia for expanded branded ophthalmic product access
Partnership aims to simplify the prescribing process and ensure accessibility and affordability for patients; company also reports new Medicare coverage for VEVYE.
Business
AlloVir and Kalaris to form retinal disease-focused company
Merger focuses on advancing clinical development of TH103, a novel differentiated anti-VEGF investigational therapy for nAMD.
Business
Tarsus names Elizabeth Yeu, MD, as new chief medical officer
Dr. Yeu will lead the company’s new medical organization as it continues the rollout of XDEMVY for Demodex blepharitis.
Business
Grifols and HHS partner on preclinical testing of OSIG drops for mustard gas eye injury
Collaboration involves evaluating investigational immunoglobulin eye drop for DED, with the potential to become a groundbreaking treatment.
Business
Bausch + Lomb names leading ophthalmologist as strategic medical advisor
Industry veteran Cathleen McCabe, MD, will consult on the company’s expanding product portfolio and serve as liaison to the global ECP community.
Business
Ocuphire Pharma just purchased Opus Genetics
Operating under the name “Opus Genetics,” the combined company features a pipeline of IRD-targeted gene therapy candidates.
Business
Scope Health purchases Eyetamins supplements
Acquisition features vision health-related products formulated with active ingredients —including AREDS-based and other clinically-backed nutrients.
Business
Alcon innovator program identifies contact lens market needs
Inaugural initiative recruits ECPs to collect patient feedback and address top barriers influencing lens wear outcomes.
Business
Mediwhale raises $12M in funding for AI-based retinal scanning tech
Financing will support the company’s AI diagnostic solutions for preventing cardiovascular, kidney, and ocular diseases.
Business
Topcon and BeeKeeper AI partner to develop AI solutions for eyecare data
Collaboration combines the Harmony and EscrowAI platforms to enable algorithm privacy and encryption for real-world eye data.
Business
Opthea appoints new CFO, other senior leadership positions
Latest appointees include CMO and VP as the company prepares for 2025 topline phase 3 data readouts on sozinibercept for wet AMD.
Business
Vista Ophthalmics and MST to launch global partnership
Collaboration marks the U.S. commercialization of the Vista 1-Step vitrector and Vista IS anterior chamber maintainer, debuting at AAO next month.
Business
Global Myopia Awareness Coalition adds international members
The Singapore Optometric Association and Optometry Australia have joined the industry coalition’s fight against myopia.
Business
Nicox and Glaukos sign global licensing option for glaucoma and retinal candidate
Agreement includes preclinical research for NCX 1728, the lead compound of a new class of nitric-oxide-donating molecule class.
Business
ANI Pharmaceuticals officially acquires Alimera Sciences
Purchase includes YUTIQ and ILUVIEN, expanding the company’s ophthalmic presence in the rare disease space.
Business
AbbVie and Ripple Therapeutics to develop glaucoma intracameral implant
Collaboration features Ripple’s RTC-620, a sustained-release drug implant with repeat dosing for lowering IOP in OAG and OHT patients.
Business
Sonoma Pharmaceuticals and EMC Pharma to co-market expanded eye care product line
Ongoing agreement now involves HOCl-based Ocucyn and Acuicyn eyelid and eyelash cleansers, with the debut targeted for AAO next month.
Business
Opthea names senior leaders ahead of phase 3 wet AMD data readout
Company anticipates releasing interim data from COAST and ShORe studies in early and mid-2025, respectively.
Business